However, acute pain episodessuch as a headache, menstrual cramp, or minor injurystill require management while you're on semaglutide
Supports bodily functions, tissue repair, and protein synthesis
The Bridge program only covers certain GLP-1 medications for weight loss like Foundayo, Wegovy (injection and tablet) and Zepbound (KwikPen only)
How Retatrutide Compares to Other Weight Loss Medications The Triple Agonist Advantage Retatrutide's unprecedented efficacy stems from its unique mechanism as a triple hormone receptor agonist , activating three complementary pathways: GLP-1 (Glucagon-Like Peptide-1): Reduces appetite, slows gastric emptying, improves insulin secretion GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances GLP-1 effects, improves insulin sensitivity, may affect fat metabolism Glucagon: Increases energy expenditure, promotes fat burning, may improve metabolic rate Head-to-Head Comparison Retatrutide's 6.2 percentage point improvement over tirzepatide and 13.7 percentage point improvement over semaglutide represents a substantial therapeutic advance
